V
138
0.00%
Close of 9 Nov 2026, in IDR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in IDR, from our data supplier.
Net income
IDR 473.99bn
FY2016FY2025
Total assets
IDR 37.69trn
FY2016FY2025
Shareholders' equity
IDR 3.77trn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Research and development | IDR 14.89bn | IDR 13.26bn | IDR 7.15bn | IDR 5.13bn | IDR 4.08bn | IDR 3.72bn | IDR 5.23bn | IDR 4.31bn | IDR 5.35bn | IDR 1.14bn |
| Operating income | IDR 767.49bn | IDR 1.94trn | IDR 424.58bn | IDR 721.13bn | IDR 543.05bn | IDR 268.13bn | IDR 246.47bn | IDR 450.31bn | IDR 549.60bn | IDR 92.49bn |
| Net income | IDR 473.99bn | IDR 69.90bn | IDR 52.36bn | IDR 112.51bn | −IDR 31.92bn | −IDR 109.27bn | IDR 49.66bn | IDR 39.17bn | IDR 94.82bn | IDR 482.87bn |
| Diluted earnings per share | 31.15 | 4.59 | 3.44 | 9.57 | -3.49 | -11.94 | 5.43 | 4.28 | 10.36 | 59.15 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | IDR 37.69trn | IDR 34.74trn | IDR 32.99trn | IDR 28.53trn | IDR 25.94trn | IDR 26.96trn | IDR 31.24trn | IDR 30.82trn | IDR 29.45trn | IDR 26.50trn |
| Cash and short-term investments | IDR 3.20trn | IDR 5.28trn | IDR 5.85trn | IDR 6.05trn | IDR 6.33trn | IDR 6.65trn | IDR 7.84trn | IDR 5.15trn | IDR 4.08trn | IDR 10.63trn |
| Total liabilities | IDR 32.07trn | IDR 29.63trn | IDR 27.98trn | IDR 23.57trn | IDR 22.28trn | IDR 23.83trn | IDR 27.74trn | IDR 27.53trn | IDR 26.09trn | IDR 23.41trn |
| Debt | IDR 3.34trn | IDR 731.97bn | IDR 676.29bn | IDR 300.67bn | IDR 82.06bn | IDR 61.08bn | IDR 1.07trn | IDR 1.30trn | IDR 38.49bn | IDR 115.26bn |
| Shareholders' equity | IDR 3.77trn | IDR 3.21trn | IDR 3.12trn | IDR 3.12trn | IDR 2.31trn | IDR 1.95trn | IDR 2.12trn | IDR 2.01trn | IDR 2.05trn | IDR 1.91trn |
| Shares outstanding | 15,217m | 15,217m | 15,217m | 11,759m | 9,150m | 9,150m | 9,150m | 9,150m | 9,151m | 8,164m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Operating income | IDR 298.10bn | IDR 477.77bn | IDR 128.17bn | IDR 387.65bn | IDR 569.03bn | IDR 477.51bn | IDR 752.80bn | IDR 274.82bn |
| Net income | IDR 71.70bn | IDR 28.65bn | IDR 22.42bn | IDR 25.70bn | IDR 404.17bn | IDR 21.70bn | IDR 15.36bn | IDR 9.84bn |
| Diluted earnings per share | 4.71 | 1.88 | 1.47 | 1.69 | 26.56 | 1.43 | 1.01 | 0.65 |
| Total assets | IDR 36.16trn | IDR 35.33trn | IDR 37.69trn | IDR 35.57trn | IDR 33.95trn | IDR 33.82trn | IDR 34.74trn | IDR 33.00trn |
| Cash and short-term investments | IDR 2.97trn | IDR 8.25trn | IDR 3.20trn | IDR 9.27trn | IDR 8.00trn | IDR 6.93trn | IDR 5.28trn | IDR 2.99trn |
| Debt | IDR 4.84trn | IDR 2.98trn | IDR 3.34trn | IDR 1.47trn | IDR 2.57trn | IDR 3.26trn | IDR 1.29trn | IDR 2.60trn |
| Shareholders' equity | IDR 3.70trn | IDR 3.73trn | IDR 3.77trn | IDR 3.79trn | IDR 3.73trn | IDR 3.22trn | IDR 3.21trn | IDR 3.24trn |
Financial ratios
Data as of 27 Aug 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Operating margin | 27.4% | 75.8% | 19.1% | 32.1% | 25.6% | 11.6% |
| Net margin | 16.9% | 2.7% | 2.4% | 5.0% | -1.5% | -4.7% |
| Return on equity | 12.6% | 2.2% | 1.7% | 3.6% | -1.4% | -5.6% |
| Return on assets | 1.3% | 0.2% | 0.2% | 0.4% | -0.1% | -0.4% |
| Revenue growth | 9.2% | 15.1% | -0.9% | 5.7% | -8.5% | -21.2% |
| Earnings growth | 578.1% | 33.5% | -53.5% | -452.5% | -70.8% | -320.1% |
| Current ratio | 1.09x | 1.02x | 0.98x | 1.04x | 1.10x | 1.02x |
| Debt to equity | 0.89x | 0.40x | 0.46x | 0.10x | 0.61x | 0.15x |
| Equity ratio | 10.0% | 9.2% | 9.5% | 10.9% | 8.9% | 7.2% |
| Interest coverage | 2.36x | 1.18x | 0.32x | 0.72x | 0.47x | 0.17x |
| R&D as a share of sales | 0.5% | 0.5% | 0.3% | 0.2% | 0.2% | 0.2% |
| Buybacks as a share of market value | 0.0% | -0.0% | -29.4% | -28.5% | 0.0% | 0.0% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 7.6% | 3.8% | 49.5% |
| Operating income | 2.1% | 23.4% | 41.8% |
| Net income | 61.5% | — | 22.7% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Operating margin | 50.6% | 39.2% | 32.7% | 25.8% |
| Net margin | 10.2% | 7.2% | 4.0% | 5.5% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 6.5 | 42.2 | 34.6 | 17.1 | -63.2 | -6.3 | 19.4 | 22.9 | 18.5 | 1.4 |
| Price to sales | 1.1 | 1.1 | 0.8 | 0.9 | 0.9 | 0.3 | 0.3 | 0.3 | 0.6 | 1.0 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.